Nisa Investment Advisors
FULC icon

Nisa Investment Advisors’s Fulcrum Therapeutics FULC Stock Holding History

Nisa Investment Advisors’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24.2K Sell
3,161
-441
-12% -$4.09K ﹤0.01% 1941
2025
Q4 		$40.7K Sell
3,602
-679
-16% -$6.91K ﹤0.01% 1686
2025
Q3 		$39.4K Hold
4,281
– – ﹤0.01% 1702
2025
Q2 		$29.5K Buy
4,281
+266
+7% +$1.42K ﹤0.01% 1759
2025
Q1 		$11.6K Buy
4,015
+2,348
+141% +$8.63K ﹤0.01% 2062
2024
Q4 		$7.83K Buy
1,667
+328
+24% +$1.21K ﹤0.01% 2187
2024
Q3 		$4.78K Sell
1,339
-203
-13% -$1.51K ﹤0.01% 2233
2024
Q2 		$9.56K Hold
1,542
– – ﹤0.01% 2167
2024
Q1 		$14.6K Hold
1,542
– – ﹤0.01% 1968
2023
Q4 		$10.4K Hold
1,542
– – ﹤0.01% 2036
2023
Q3 		$6.85K Hold
1,542
– – ﹤0.01% 2241
2023
Q2 		$5.09K Buy
1,542
+42
+3% +$123 ﹤0.01% 2323
2023
Q1 		$4K Sell
1,500
-152
-9% -$1.36K ﹤0.01% 2261
2022
Q4 		$12K Buy
1,652
+509
+45% +$3.32K ﹤0.01% 2166
2022
Q3 		$9K Buy
1,143
+920
+413% +$6.59K ﹤0.01% 2210
2022
Q2 		$1K Sell
223
-16,977
-99% -$166K ﹤0.01% 2359
2022
Q1 		$407K Buy
17,200
+14,840
+629% +$210K ﹤0.01% 1142
2021
Q4 		$29K Sell
2,360
-3,590
-60% -$71.1K ﹤0.01% 1856
2021
Q3 		$168 Buy
5,950
+900
+18% +$17.1K ﹤0.01% 1475
2021
Q2 		$53 Buy
+5,050
New +$51.1K ﹤0.01% 1923

Other funds holding FULC

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
FTM
First Turn Management Del Mar, California $895M AUM 261.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Nisa Investment Advisors's FULC Position: Q1 2026 in Review

Nisa Investment Advisors reduced its Fulcrum Therapeutics (FULC) stake by 12% in Q1 2026, selling an estimated $4.09K and leaving 3,161 shares worth $24.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1941.

Nisa Investment Advisors first reported a position in FULC in Q2 2021 and has held it in 20 quarters since. The position peaked at $407K in Q1 2022. 169 funds tracked by Wall St. Rank hold FULC as of Q1 2026.

  • Nisa Investment Advisors held 3,161 shares of Fulcrum Therapeutics worth $24.2K as of Q1 2026.
  • Nisa Investment Advisors sold 441 Fulcrum Therapeutics shares in Q1 2026, an estimated $4.09K.
  • Fulcrum Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #1941 holding.
  • Nisa Investment Advisors first reported a position in Fulcrum Therapeutics in Q2 2021 and has held it in 20 quarters since.
  • Nisa Investment Advisors's Fulcrum Therapeutics position peaked at $407K in Q1 2022.
  • 169 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.